{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Control+Study+Product&page=73", "query": { "intervention": "Control Study Product", "page": 73 }, "page_size": 10 }, "pagination": { "page": 73, "page_size": 10, "total_count": 4241, "total_pages": 425, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Control+Study+Product&page=74&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Control+Study+Product&page=72&page_size=10" }, "source": "remote", "last_synced_at": "2026-11-03T07:55:58.151Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT04922645", "title": "Auryxia (Ferric Citrate) Therapy for In-Center and Home Dialysis Participants", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Hyperphosphatemia", "Anemia, Iron Deficiency", "Renal Insufficiency" ], "interventions": [ { "name": "Ferric Citrate 1 gram Oral Tablet", "type": "DRUG" }, { "name": "Standard of care phosphate-lowering therapy", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "USRC Kidney Research", "sponsor_class": "NETWORK", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 214, "start_date": "2021-06-29", "completion_date": "2022-09-15", "has_results": false, "last_update_posted_date": "2022-11-07", "last_synced_at": "2026-11-03T07:55:58.151Z", "location_count": 13, "location_summary": "Anchorage, Alaska • Mesa, Arizona • Pine Bluff, Arkansas + 6 more", "locations": [ { "city": "Anchorage", "state": "Alaska" }, { "city": "Mesa", "state": "Arizona" }, { "city": "Pine Bluff", "state": "Arkansas" }, { "city": "Granada Hills", "state": "California" }, { "city": "Dalton", "state": "Georgia" } ], "official_url": "https://clinicaltrials.gov/study/NCT04922645" }, { "nct_id": "NCT00808665", "title": "Intraoperative Infusion of Precedex to Reduce Length of Stay After Lumbar Spine Fusion", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Spinal Fusion Acquired", "Spinal Stenosis", "Lesions of Lumbosacral Intervertebral Disc", "Spinal Diseases" ], "interventions": [ { "name": "Dexmedetomidine", "type": "DRUG" }, { "name": "0.9% Saline", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Vanderbilt University Medical Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "85 Years", "sex": "ALL", "summary": "18 Years to 85 Years" }, "enrollment_count": 68, "start_date": "2009-06", "completion_date": "2012-12", "has_results": true, "last_update_posted_date": "2018-05-25", "last_synced_at": "2026-11-03T07:55:58.151Z", "location_count": 1, "location_summary": "Nashville, Tennessee", "locations": [ { "city": "Nashville", "state": "Tennessee" } ], "official_url": "https://clinicaltrials.gov/study/NCT00808665" }, { "nct_id": "NCT00423319", "title": "Study of an Investigational Drug for the Prevention of Thrombosis-related Events Following Hip Replacement Surgery (ADVANCE-3)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Deep Vein Thrombosis", "Pulmonary Embolism" ], "interventions": [ { "name": "Enoxaparin", "type": "DRUG" }, { "name": "Apixaban", "type": "DRUG" }, { "name": "Enoxaparin-matching placebo", "type": "DRUG" }, { "name": "Apixaban-matching placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Bristol-Myers Squibb", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 5407, "start_date": "2007-03", "completion_date": "2009-09", "has_results": true, "last_update_posted_date": "2014-05-14", "last_synced_at": "2026-11-03T07:55:58.151Z", "location_count": 19, "location_summary": "Birmingham, Alabama • Little Rock, Arkansas • Sacramento, California + 12 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Birmingham", "state": "Alabama" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "Sacramento", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00423319" }, { "nct_id": "NCT03037307", "title": "A Clinical Bite Force Study of Two Marketed Adhesives Against no Adhesive", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Denture Retention" ], "interventions": [ { "name": "Test Product", "type": "OTHER" }, { "name": "Positive Contol", "type": "OTHER" }, { "name": "Negative Control", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "85 Years", "sex": "ALL", "summary": "18 Years to 85 Years" }, "enrollment_count": 44, "start_date": "2017-02-13", "completion_date": "2017-05-04", "has_results": true, "last_update_posted_date": "2018-08-31", "last_synced_at": "2026-11-03T07:55:58.151Z", "location_count": 1, "location_summary": "Indianapolis, Indiana", "locations": [ { "city": "Indianapolis", "state": "Indiana" } ], "official_url": "https://clinicaltrials.gov/study/NCT03037307" }, { "nct_id": "NCT00057707", "title": "Effects of Modafinil on Brain Function in Patients With Schizophrenia", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Schizophrenia", "Schizoaffective Disorder" ], "interventions": [ { "name": "Modafinil", "type": "DRUG" }, { "name": "Functional MRI", "type": "PROCEDURE" }, { "name": "Neuropsychological Testing", "type": "PROCEDURE" } ], "intervention_types": [ "DRUG", "PROCEDURE" ], "sponsor": "National Institute of Mental Health (NIMH)", "sponsor_class": "NIH", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "50 Years", "sex": "ALL", "summary": "18 Years to 50 Years" }, "enrollment_count": 176, "start_date": "2003-03-26", "completion_date": "2017-06-16", "has_results": false, "last_update_posted_date": "2019-12-09", "last_synced_at": "2026-11-03T07:55:58.151Z", "location_count": 1, "location_summary": "Bethesda, Maryland", "locations": [ { "city": "Bethesda", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT00057707" }, { "nct_id": "NCT03567694", "title": "Single and Multiple Doses of HA115 and Food Effect in Healthy Adult Volunteers", "overall_status": "WITHDRAWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Asthma" ], "interventions": [ { "name": "HA115", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Conjupro Biotherapeutics, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "55 Years", "sex": "ALL", "summary": "18 Years to 55 Years" }, "enrollment_count": 0, "start_date": "2021-10-01", "completion_date": "2022-10-12", "has_results": false, "last_update_posted_date": "2021-09-08", "last_synced_at": "2026-11-03T07:55:58.151Z", "location_count": 1, "location_summary": "Long Beach, California", "locations": [ { "city": "Long Beach", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT03567694" }, { "nct_id": "NCT05894239", "title": "A Study to Evaluate the Efficacy and Safety of Inavolisib in Combination With Phesgo Versus Placebo in Combination With Phesgo in Participants With PIK3CA-Mutated HER2-Positive Locally Advanced or Metastatic Breast Cancer", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Metastatic Breast Cancer" ], "interventions": [ { "name": "Inavolisib", "type": "DRUG" }, { "name": "Phesgo", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" }, { "name": "Taxane-based Chemotherapy", "type": "DRUG" }, { "name": "Optional Endocrine Therapy of Investigator's Choice", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Hoffmann-La Roche", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 230, "start_date": "2023-09-08", "completion_date": "2032-12-28", "has_results": false, "last_update_posted_date": "2026-10-16", "last_synced_at": "2026-11-03T07:55:58.151Z", "location_count": 20, "location_summary": "Gilbert, Arizona • Burbank, California • Corona, California + 17 more", "locations": [ { "city": "Gilbert", "state": "Arizona" }, { "city": "Burbank", "state": "California" }, { "city": "Corona", "state": "California" }, { "city": "Duarte", "state": "California" }, { "city": "Irvine", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT05894239" }, { "nct_id": "NCT00955981", "title": "Gout Dose Response Study", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Hyperuricemia" ], "interventions": [ { "name": "RDEA594", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Ardea Biosciences, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 123, "start_date": "2009-07", "completion_date": "2011-09", "has_results": false, "last_update_posted_date": "2014-03-07", "last_synced_at": "2026-11-03T07:55:58.151Z", "location_count": 4, "location_summary": "Los Angeles, California • DeLand, Florida • Winston-Salem, North Carolina + 1 more", "locations": [ { "city": "Los Angeles", "state": "California" }, { "city": "DeLand", "state": "Florida" }, { "city": "Winston-Salem", "state": "North Carolina" }, { "city": "Jackson", "state": "Tennessee" } ], "official_url": "https://clinicaltrials.gov/study/NCT00955981" }, { "nct_id": "NCT05683457", "title": "A Study to Evaluate the Efficacy, Safety, and Immunogenicity of mRNA-1647 Cytomegalovirus (CMV) Vaccine in Allogenic Hematopoietic Cell Transplantation (HCT) Participants.", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Cytomegalovirus Infection" ], "interventions": [ { "name": "mRNA-1647", "type": "BIOLOGICAL" }, { "name": "Placebo", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "ModernaTX, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 84, "start_date": "2023-04-05", "completion_date": "2027-03-06", "has_results": false, "last_update_posted_date": "2026-08-10", "last_synced_at": "2026-11-03T07:55:58.151Z", "location_count": 3, "location_summary": "Boston, Massachusetts • St Louis, Missouri • Seattle, Washington", "locations": [ { "city": "Boston", "state": "Massachusetts" }, { "city": "St Louis", "state": "Missouri" }, { "city": "Seattle", "state": "Washington" } ], "official_url": "https://clinicaltrials.gov/study/NCT05683457" }, { "nct_id": "NCT05766267", "title": "Short-course Regimens for the Treatment of Pulmonary Tuberculosis", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2", "PHASE3" ], "conditions": [ "Tuberculosis, Pulmonary", "Tuberculosis Infection" ], "interventions": [ { "name": "Rifabutin", "type": "DRUG" }, { "name": "Delamanid", "type": "DRUG" }, { "name": "Bedaquiline", "type": "DRUG" }, { "name": "Moxifloxacin", "type": "DRUG" }, { "name": "Pyrazinamide", "type": "DRUG" }, { "name": "Isoniazid", "type": "DRUG" }, { "name": "Rifampin", "type": "DRUG" }, { "name": "Ethambutol", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Centers for Disease Control and Prevention", "sponsor_class": "FED", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": null, "sex": "ALL", "summary": "12 Years and older" }, "enrollment_count": 288, "start_date": "2023-11-21", "completion_date": "2027-12-31", "has_results": false, "last_update_posted_date": "2026-09-21", "last_synced_at": "2026-11-03T07:55:58.151Z", "location_count": 1, "location_summary": "Seattle, Washington", "locations": [ { "city": "Seattle", "state": "Washington" } ], "official_url": "https://clinicaltrials.gov/study/NCT05766267" } ] }